Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
주식 순위 #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
주가
$4.66
시가총액
$43.92M
변동 (1일)
-0.63%
변동 (1년)
338.04%
국가
FR
거래 Theranexus Société Anonyme (ALTHX)

카테고리

Theranexus Société Anonyme (ALTHX)의 EPS
December 2025 기준 EPS TTM: $-0.26
Theranexus Société Anonyme의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.26입니다. 2023년 말에는 회사의 EPS가 $-0.97였으며, 이는 2022년의 EPS $-1.33와 감소입니다.
Theranexus Société Anonyme의 EPS 기록 (2015 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-0.26 17.32%
2024 $-0.22 -77.54%
2023 $-0.97 -26.86%
2022 $-1.33 -29.54%
2021 $-1.89 31.35%
2020 $-1.44 -17.37%
2019 $-1.74 -10.98%
2018 $-1.95 139.44%
2017 $-0.82 -56.68%
2016 $-1.88 199.05%
2015 $-0.63 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$4.36 -1,788.61%
DK
$17.01 -6,690.47%
US
$42.53 -16,578.11%
US
$9.62 -3,827.55%
BE
$26.66 -10,429.33%
NL